Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood test may predict sepsis death risk within 28 days

NCT ID NCT06654895

Recruiting now Diagnosis Sponsor: Bluejay Diagnostics, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether measuring a substance called IL-6 in the blood can help predict which patients with sepsis or septic shock are most likely to die within 28 days. Researchers will enroll 700 adults in intensive care units (ICUs) and follow them for 28 days. If the test works, it could give doctors a fast way to identify high-risk patients and tailor their care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
IL-6 blood test (diagnostic device)
What this could lead to
If successful, this could give doctors a quick, reliable tool to identify which sepsis patients are at highest risk of dying within 28 days, helping them make faster treatment decisions.
What could go wrong
This is a validation study, not a treatment trial. The test may not prove accurate enough to change patient outcomes, and results may not apply to all hospital settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPSIS, SEPTIC SHOCK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Infections infectious disease with sepsis Inflammation Pathologic Processes Sepsis Shock Systemic Inflammatory Response Syndrome toxic shock syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SEPSIS, SEPTIC SHOCK

Contacts and locations

Locations

  • Beth Israel Deaconess Medical Center

    RECRUITING

    Boston, Massachusetts, 02215, United States

  • Intermountain Health

    RECRUITING

    Salt Lake City, Utah, 84111, United States

  • University of Florida College of Medicine

    RECRUITING

    Gainesville, Florida, 32610, United States

  • Vanderbilt University Medical Center

    RECRUITING

    Nashville, Tennessee, 37232, United States

    Contact Email: •••••@•••••

  • Wake Forest School of Medicine

    RECRUITING

    Winston-Salem, North Carolina, 27157, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.